Asparagus racemosus Willd (Liliaceae) ameliorates early diabetic nephropathy in STZ induced diabetic rats

Department of Pharmacology, Smt. Kashibai Navale College of Pharmacy, Pune 411 048, India.
Indian journal of experimental biology (Impact Factor: 0.84). 07/2012; 50(7):469-75.
Source: PubMed


Diabetic nephropathy is a major "microvascular" complication of diabetes, differs from other causes of chronic kidney diseases in its predictability, with well-defined functional progression from hyperfiltration to micro- to macroalbuminuria to renal failure. The present study was undertaken to investigate the effect of Asparagus racemosus Willd (Liliaceae) on streptozotocin-induced early diabetic nephropathy. Single i.p injection of streptozotocin (55 mg/kg) was administered to induce early diabetic nephropathy in Wistar rats and thereafter treated orally with ethanolic extract of Asparagus racemosus (EEAR) at a dose level of 100 and 250 mg/kg daily for 4 weeks. The efficacy of extract was compared with diabetic control rats. A. racemosus treatment significantly decreased plasma glucose, creatinine, urea nitrogen, total cholesterol and triglyceride levels. Renal hypertrophy, polyuria, hyperfiltration, microalbuminuria and abnormal changes in the renal tissue as well as oxidative stress were effectively attenuated by EEAR treatment. Basement membrane thickening and mesangial proliferation formation without nodules were seen in diabetic rats, whereas these structural changes were reduced in EEAR treated groups. Results of this study suggested that A. racemosus has beneficial effect in the treatment of diabetic

Download full-text


Available from: D. P Jain, Dec 06, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes was induced in male adult albino rats by injecting streptozotocin (65 mg/kg b.wt., i.p.) and left untreated for 9 weeks for the development of nephropathy. Animals were treated with methanolic extract of Murraya koenigii (L.) Spreng leaf (MEMK) at two dose levels (200 mg/kg and 400mg/kg) and with standard drug Glimipride (2mg/kg) for 40 days in order to analyse its renoprotective effect, by evaluating metabolic profile, renal function test, electrolyte concentration in blood and urine along with its antioxidant status and histopathological studies. Nephropathy was noted in diabetic rats between 8th-9th week by assessing significant increase in polyuria, proteinuria, serum glucose, albuminuria, creatinine and blood urea nitrogen levels. On 40 days of treatment of MEMK, serum glucose, total cholesterol, HDL- cholesterol, triglyceride including the kidney functions were greatly improved as evidenced by amelioration of blood urea nitrogen, creatinine, serum inulin, total protein concentration, albumin and serum electrolytes (Type IV renal tubular acidosis) and also improvement in antioxidant with decrease in malodialdehyde and increase in catalase, superoxide dismutase and glutathione-s-transferase levels. Histopathological studies of nephropathic animals showed chronic glomerulonephritis with marked improvementin treatment groups. Data from this study suggest that M. koenigii (L.) Spreng leaf possesses a protective effect and attenuates the progression of diabetic nephropathy in animals.
    International Journal of Pharma and Bio Sciences 01/2013; 4(3):P678-P693.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diabetic nephropathy (DN) has a complex pathogenesis and poor prognosis due to the lack of therapeutic interventions. The present study investigates the effect of A. marmelos leaf extract (AME) on early alloxan induced DN. The treatment with AME was found to significantly decrease the fasting blood sugar, total cholesterol, blood urea, creatinine and renal TBARS and increased the levels of renal reduced glutathione and catalase significantly as compared to the diabetic control group. The maximum dose-dependent protection was observed at a dose of 200 mg kg(-1). Histological examination revealed marked reversal of the morphological derangements with AME treatment as indicated by a decrease in glomerular expansion, tubular dilatation and inflammatory cells. The present results conclude that AME treatment has a significant ameliorative effect on early changes induced in the kidneys by alloxan and improves the outcome of DN.
    Indian journal of experimental biology 06/2013; 51(6):464-9. · 0.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study is to evaluate the anti-diabetic effects of the alpha-glucosidase inhibitor valibose in a streptozotocin (STZ)-induced type 1 diabetes rat model. Diabetes was induced by a single dose of STZ (58 mg x kg(-1), ip) in SD rats, rats with elevated fasting blood glucose levels (250-450 mg x dL(-1)) were selected and divided into five groups (n = 10 in each). Another ten normal SD rats were chosen as normal group. Valibose mixed with the high sucrose diets (0.4, 1.0 and 2.5 mg 100 g(-1) diets) or acarbose (30 mg x 100 g(-1) diets) was administrated in the diabetic rats for about 5 weeks. In all groups, fasting and postprandial plasma glucose, plasma lipids, glycosylated serum protein, N-acetyl-beta-D-glucosaminidase (NAG), creatinine (Cre), blood urea nitrogen (BUN) and urine sugar levels were determined during the treatment. At the end of the experiment, the morphological alterations in kidney were evaluated by hematoxylin-eosin (HE) staining. After 3-weeks administration, valibose significantly decreased postprandial and fasting blood glucose, urine glucose, and reduced the levels of serum fructosamine. Valibose also decreased plasma triglyceride and cholesterol levels after 4 weeks treatment. These results indicated that valibose ameliorated metabolic disturbance of glucose and lipids in STZ-induced diabetic rats. In addition, valibose markedly reduced level of serum NAG and BUN, and decreased the weight index of kidney. HE staining showed reduced kidney pathological changes after valibose treatment. The findings of the present study indicate that valibose may be a novel alpha-glucosidase inhibitor for the prevention from hyperglycemia in STZ-induced type 1 diabetes rats. And valibose might have a potential role for protecting against diabetic nephropathy during hyperglycemia.
    Yao xue xue bao = Acta pharmaceutica Sinica 08/2013; 48(8):1227-32.
Show more